Pleural Fluid Amino-Terminal Brain Natriuretic Peptide in Patients With Pleural Effusions

Autor: Gulsevil Ozgul, Beste Ozben, Sait Karakurt, Azra Meryem Tanrikulu, Yasin Abul, Nurhayat Topaloglu, Ahmet Oktay, Altug Cincin
Přispěvatelé: Cincin, Altug, Abul, Yasin, Ozben, Beste, Tanrikulu, Azra, Topaloglu, Nurhayat, Ozgul, Gulsevil, Karakurt, Sait, Oktay, Ahmet
Jazyk: angličtina
Rok vydání: 2013
Předmět:
Male
Pathology
Pleural effusion
BIOCHEMICAL PARAMETERS
medicine.medical_treatment
heart failure
Critical Care and Intensive Care Medicine
Gastroenterology
SERUM
pleural effusion
Cytology
Positive predicative value
Natriuretic Peptide
Brain

Natriuretic peptide
Medicine
Diuretics
UTILITY
ALBUMIN GRADIENT
Exudates and Transudates
General Medicine
Middle Aged
respiratory system
Brain natriuretic peptide
Light's criteria
Predictive value of tests
SEPARATION
HEART-FAILURE
Female
Adult
Pulmonary and Respiratory Medicine
medicine.medical_specialty
NT-PROBNP
medicine.drug_class
Thoracentesis
DIAGNOSIS
Diagnosis
Differential

Predictive Value of Tests
Internal medicine
DISTINGUISH
Humans
Tuberculosis
Empyema
Aged
business.industry
medicine.disease
Peptide Fragments
DYSFUNCTION
Pleural Effusion
Malignant

respiratory tract diseases
ROC Curve
Heart failure
amino-terminal brain natriuretic peptide
business
Biomarkers
Popis: BACKGROUND: Definite diagnosis of transudative or exudative pleural fluids often presents a diagnostic dilemma. The aim of this study was to evaluate whether amino-terminal brain natriuretic peptide (NT-proBNP) levels in pleural fluid has a diagnostic value for discriminating heart-failure-related pleural effusions from non-heart-failure effusions. METHODS: Sixty-six subjects (40 male, mean age 61 ± 18 y) with pleural effusions were included. Samples of pleural fluid and serum were obtained simultaneously from each subject. Biochemical analysis, bacterial and fungal culture, acid-fast bacilli smear and culture, and cytology were performed on the pleural fluid. RESULTS: Subjects with heart-failure-related pleural effusion had significantly higher pleural NT-proBNP levels than other subjects ( P < .001). Pleural and serum NT-proBNP measures were closely correlated (r = 0.90, P < .001). An NT-proBNP cutoff value of ≥ 2,300 pg/mL in pleural fluid had a sensitivity of 70.8%, a specificity of 97.6%, and positive and negative predictive values of 94.4% and 85.4%, respectively, for discriminating transudates caused by heart failure from exudates. Eight heart-failure subjects were misclassified as exudates by Light's criteria, 5 of whom received diuretics before thoracentesis. All misclassified subjects had pleural NT-proBNP levels higher than 1,165 pg/mL, which predicted heart-failure-associated transudates with 95.8% sensitivity and 85.7% specificity. CONCLUSIONS: Pleural fluid NT-proBNP measurement in the routine diagnostic panel may be useful in differentiation of heart-failure-related pleural effusions and exudative pleural fluids with reasonable accuracy, especially in heart-failure patients treated with diuretics.
Databáze: OpenAIRE